Cody Miller
Psychiatry · Mobile, ALNPI 1871298448
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,930, more than ten times the $76 reported in 2023.
Across 116 payments — averaging $23.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$402
- Alkermes, Inc.$344
- Otsuka America Pharmaceutical, Inc.$316
- Neurocrine Biosciences, Inc.$285
- Vanda Pharmaceuticals Inc.$285
- Corium, LLC$258
- plus $833 from 13 others
What the payments were for
- Food & beverage$2,67698%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $402 |
| Alkermes, Inc. | 14 | $344 |
| Otsuka America Pharmaceutical, Inc. | 17 | $316 |
| Neurocrine Biosciences, Inc. | 10 | $285 |
| Vanda Pharmaceuticals Inc. | 9 | $285 |
| Corium, LLC | 13 | $258 |
| Johnson & Johnson | 10 | $221 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $193 |
| AbbVie | 6 | $114 |
| E.r. Squibb & Sons, L.L.C. | 4 | $89 |
| Indivior Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $39 |
| Genentech USA, Inc. | 1 | $24 |
| UCB, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| AstraZeneca | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Neos Therapeutics, LP | 1 | $15 |
How this compares
$2,723 in reported general payments places this provider in the 75th percentile of 400 psychiatry providers in Alabama.
Other psychiatry in Mobile
- Mark HaygoodMobile$348K
- Bradley SadlerMobile$124K
- Michael MarshallMobile$59K
- Mary Cohen ColsonMobile$10K
- Lucas BooneMobile$10K
- Bradley BrooksMobile$6K
- Sandra ParkerMobile$5K
- Armand SchachterBirmingham$758K
- Stephen HughesBirmingham$683K
- Leesha Ellis CoxBirmingham$653K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.